SCHEMBL20042707

SCHEMBL20042707

Cc1cc(OC(F)(F)F)cc(C(=O)N2Cc3nc(C)nc(N4CCC4)c3C2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 4/20 0.40
MAPK7 Q13164 3/20 0.35
HPGD P15428 2/20 0.35
MGLL Q99685 2/20 0.35
TSHR P16473 2/20 0.35
KDM4E B2RXH2 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
HSD17B10 Q99714 1/20 0.35
FFAR4 Q5NUL3 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CFTR P13569 2/20 0.33
PIK3CD O00329 1/20 0.33
PIK3R1 P27986 1/20 0.33
PIK3CA P42336 1/20 0.33
PIK3CB P42338 1/20 0.33
PIK3CG P48736 1/20 0.33
PIK3R5 Q8WYR1 1/20 0.33
EPHX2 P34913 1/20 0.33
TRPM8 Q7Z2W7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20042861 0.91 P2RX7 (0.39) P2RX7MAPK7HPGDMGLLTSHR
SCHEMBL20042705 0.87 EPHX2 (0.45) P2RX7MAPK7MGLLEPHX2TRPM8
SCHEMBL20042854 0.82 GRM5 (0.42) P2RX7HPGDTSHRKDM4ECASP1
SCHEMBL20043028 0.81 KDM4E (0.40) P2RX7HPGDTSHRKDM4ECASP1
SCHEMBL20042780 0.81 P2RX7 (0.43) P2RX7MAPK7MGLLEPHX2
SCHEMBL20042694 0.81 P2RX7 (0.43) P2RX7MAPK7HPGDMGLLTSHR
SCHEMBL20042765 0.80 P2RX7 (0.42) P2RX7MAPK7HPGDMGLLEPHX2
SCHEMBL20042829 0.80 P2RX7 (0.41) P2RX7HPGDTSHRKDM4ECASP1
SCHEMBL20042743 0.80 P2RX7 (0.40) P2RX7HPGDTSHRKDM4ECASP1
SCHEMBL20042873 0.79 P2RX7 (0.38) P2RX7HPGDTSHRKDM4ECASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018066718-A1 THERAPEUTIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-04-12 WO disclosed